MIC (Minimum Inhibitory Concentration) Test: What It Is, Why It's Done, and What Your Results Mean
A laboratory test that measures how effective the antibiotic bedaquiline is against tuberculosis bacteria to help guide treatment for drug-resistant TB.
{"This test determines if bedaquiline can effectively treat your tuberculosis infection","It measures the minimum drug concentration needed to stop bacterial growth","Results help your doctor choose the right antibiotic treatment","Sample is usually collected from sputum or other respiratory specimens","Lower MIC values mean the bacteria are more susceptible to the drug"}
Key facts at a glance
- LOINC
- 88703-4
- Short code
- BDQ MIC
- Synonyms
- Bedaquiline Islt MIC
- Category
- chemistry
- Sample
- serum
- Container
- Sterile, leak-proof, screw-cap container appropriate for mycobacterial culture (e.g., 50 mL conical centrifuge tube or sterile cryovial)
- Units
- N/A
- Ref low
- 0
- Ref high
- 0.25
- Critical range
- — – 1 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Broth microdilution Minimum Inhibitory Concentration (MIC) method
- CPT
- 87188
- SNOMED
- 428931000124101
- Specimen volume
- Minimum 1-5 mL of liquid culture (e.g., MGIT broth) in exponential growth phase; solid medium subcultures require a visible colony sweep
- Stability
- Isolates should be processed within 24 hours of culture positivity when stored at 2-8°C. Live cultures can be stored long-term at -70°C in 20% glycerol.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 168–336 hours
- Order
- routine
What is the MIC test and what does it tell my doctor about treating my infection?
The Bedaquiline Susceptibility Test by Minimum Inhibitory Concentration (MIC) is a laboratory test that determines how well the antibiotic bedaquiline can stop the growth of tuberculosis (TB) bacteria. This test is specifically used for patients with drug-resistant forms of TB, where standard antibiotics may not work effectively.
How does the MIC test work in the laboratory to measure how much antibiotic is needed to stop bacteria from growing?
The test exposes TB bacteria collected from your sample to different concentrations of bedaquiline in a laboratory setting. Scientists then observe the lowest concentration of the drug that prevents the bacteria from growing. This concentration is called the Minimum Inhibitory Concentration (MIC). A lower MIC means the bacteria are more easily killed by the drug.
Why is the MIC test performed, and when might my doctor order it for me or my child?
This test is primarily performed when a patient has been diagnosed with tuberculosis that is resistant to standard first-line antibiotics. It helps your healthcare provider determine whether bedaquiline will be an effective part of your treatment plan. Bedaquiline is an important antibiotic used specifically for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).
How is the sample collected for MIC testing, and what should I expect during the collection process?
For this test, a sample is typically collected from your respiratory system. The most common sample is sputum (mucus from your lungs), which you can cough up in the morning. In some cases, other respiratory samples may be collected, such as fluid from bronchoscopy or tissue samples. For certain types of testing, blood (serum) may also be used to measure drug levels in your body.
What do the results of my MIC test mean, and how will my doctor use them to choose the right antibiotic?
Your test results will show an MIC value, which is compared to established clinical breakpoints. If the MIC is at or below the susceptible breakpoint, the TB bacteria are considered likely to respond to bedaquiline treatment. If the MIC is above the resistant breakpoint, it indicates the bacteria may be resistant to bedaquiline, and your doctor will need to consider alternative treatments. Your doctor will interpret these results in the context of your overall health and other test results.
Reference range
Susceptible: MIC ≤ 0.25 μg/mL; Intermediate: MIC 0.5 μg/mL; Resistant: MIC ≥ 1.0 μg/mL (per CLSI M24 and WHO critical concentrations for Mycobacterium tuberculosis complex)N/A
No special patient preparation is required. Specimen should be collected prior to administration of the next dose of anti-tuberculosis therapy when monitoring therapeutic drug levels. Avoid contaminating specimen collection with environmental mycobacteria.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The Bedaquiline MIC test is clinically significant because it directly guides treatment decisions for drug-resistant tuberculosis. Bedaquiline is a critical second-line antibiotic for MDR-TB and XDR-TB, and knowing whether the bacteria are susceptible helps doctors create an effective treatment regimen. This personalized approach can improve treatment outcomes and help avoid using ineffective antibiotics. The test also helps monitor for the development of drug resistance during treatment.
Frequently asked questions
Is this test painful?
How long does it take to get results?
Do I need to prepare for this test?
What happens if my test shows resistance to bedaquiline?
Can this test be done during treatment?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy